Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: A pilot study

Lupus

Volumn 21, Issue 1, 2012, Pages 13-26

  Batal, I ^a   Liang, K ^a   Bastacky, S ^a   Kiss, L P ^a   McHale, T ^a   Wilson, N L ^a,b   Paul, B ^a   Lertratanakul, A ^a   Ahearn, J M ^a,b   Manzi, S M ^a,b,c   Kao, A H ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ALLEGHENY HEALTH NETWORK   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

C4d immunostain; erythrocyte bound C4d; lupus nephritis; platelet bound C4d; reticulocyte bound C4d

Indexed keywords

AZATHIOPRINE; CD4 ANTIGEN; CREATININE; CYCLOPHOSPHAMIDE; DNA ANTIBODY; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE MARKER; ELECTRON MICROSCOPY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; GLOMERULUS; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY INTERSTITIUM; KIDNEY PARENCHYMA; KIDNEY TUBULE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; QUANTITATIVE ASSAY; RETICULOCYTE; THROMBOCYTE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; COHORT STUDIES; COMPLEMENT C4B; ERYTHROCYTES; FEMALE; HUMANS; KIDNEY GLOMERULUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PILOT PROJECTS; PROSPECTIVE STUDIES; RETICULOCYTES; YOUNG ADULT;

EID: 83655172400     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311422093     Document Type: Article

References (38)

1. Liu CC, Manzi S, Ahearn JM. Biomarkers for systemic lupus erythematosus: a review and perspective. Curr Opin Rheumatol. 2005 ; 17: 543-549 (Pubitemid 41527813)
2. Balow JE. Clinical presentation and monitoring of lupus nephritis. Lupus. 2005 ; 14: 25-30 (Pubitemid 40216064)
3. Min DJ, Kim SJ, Park SH, et al. Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol. 2002 ; 20: 13-18
4. Li SJ, Liu ZH, Zen CH, Wang QW, Wang Y, Li LS. Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection. Lupus. 2007 ; 16: 875-880 (Pubitemid 350157273)
5. Cohen D, Koopmans M, Kremer Hovinga IC, et al. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Arthritis Rheum. 2008 ; 58: 2460-2469
6. Liu CC, Ahearn JM. The search for lupus biomarkers. Best Pract Res Clin Rheumatol. 2009 ; 23: 507-523
7. Kao AH, Navratil JS, Ruffing MJ, et al. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus. Arthritis Rheum. 2010 ; 62: 837-844
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725
9. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277 (Pubitemid 13221242)
10. Austin HA, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983 ; 75: 382-391 (Pubitemid 13005770)
11. Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984 ; 25: 689-695 (Pubitemid 14079965)
12. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004 ; 15: 241-250 (Pubitemid 38140764)
13. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004 ; 65: 521-530 (Pubitemid 38130646)
14. Batal I, Girnita A, Zeevi A, et al. Clinical significance of the distribution of C4d deposits in different anatomic compartments of the allograft kidney. Mod Pathol. 2008 ; 21: 1490-1498
15. Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant. 2007 ; 22: 568-576 (Pubitemid 46189903)
16. Regele H, Exner M, Watschinger B, et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant. 2001 ; 16: 2058-2066 (Pubitemid 32970570)
17. Kim SH, Jeong HJ. Glomerular C4d deposition indicates in situ classic complement pathway activation, but is not a marker for lupus nephritis activity. Yonsei Med J. 2003 ; 44: 75-80 (Pubitemid 36322517)
18. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008 ; 8: 753-760 (Pubitemid 351347767)
19. Manzi S, Navratil JS, Ruffing MJ, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum. 2004 ; 50: 3596-3604 (Pubitemid 39488685)
20. Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Arthritis Rheum. 2005 ; 52: 3087-3099 (Pubitemid 41447090)
21. Navratil JS, Manzi S, Kao AH, et al. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 670-674 (Pubitemid 43228646)
22. Liu CC, Ahearn JM, Manzi S. Complement as a source of biomarkers in systemic lupus erythematosus: past, present, and future. Curr Rheumatol Rep. 2004 ; 6: 85-88
23. Valentijn RM, van Overhagen H, Hazevoet HM, et al. The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 1985 ; 28: 904-913 (Pubitemid 15021485)
24. Campbell RD, Gagnon J, Porter RR. Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. Biochem J. 1981 ; 199: 359-370 (Pubitemid 12216742)
25. Chaplin H, Coleman ME, Monroe MC. In vivo instability of red-blood-cell-bound C3d and C4d. Blood. 1983 ; 62: 965-971 (Pubitemid 14237316)
26. Liu CC, Manzi S, Kao AH, Navratil JS, Ahearn JM. Cell-bound complement biomarkers for systemic lupus erythematosus: from benchtop to bedside. Rheum Dis Clin North Am. 36: 161-172
27. Baldwin WM, Kasper EK, Zachary AA, Wasowska BA, Rodriguez ER. Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant. 2004 ; 4: 311-318 (Pubitemid 38282285)
28. Koller H, Steurer W, Mark W, et al. Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases. Transpl Int. 2004 ; 17: 177-181 (Pubitemid 38758182)
29. Colvin RB. Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol. 2007 ; 18: 1046-1056 (Pubitemid 46536891)
30. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int. 1993 ; 43: 1333-1338 (Pubitemid 23161421)
31. Herzenberg AM, Gill JS, Djurdjev O, Magil AB. C4d deposition in acute rejection: an independent long-term prognostic factor. J Am Soc Nephrol. 2002 ; 13: 234-241 (Pubitemid 34042033)
32. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant. 2003 ; 3: 708-714 (Pubitemid 36745243)
33. Lerut E, Kuypers D, Van Damme B. C4d deposition in the peritubular capillaries of native renal biopsies. Histopathology. 2005 ; 47: 430-432 (Pubitemid 41428493)
34. Dhobale S, Bedetti C, Killian P, et al. IgG4 related sclerosing disease with multiple organ involvements and response to corticosteroid treatment. J Clin Rheumatol. 2009 ; 15: 354-357
35. Batal I, Domsic RT, Shafer A, et al. Renal biopsy findings predicting outcome in scleroderma renal crisis. Hum Pathol. 2009 ; 40: 332-340
36. Batal I, Chalasani G, Wu C, Shapiro R, Bastacky S, Randhawa P. Deposition of complement product C4d in anti-glomerular basement membrane glomerulonephritis. Am J Kidney Dis. 2009 ; 53: 1098-1101
37. Segawa Y, Hisano S, Matsushita M, et al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr Nephrol. 2010 ; 25: 1091-1099
38. Mehta N, Uchino K, Fakhran S, et al. Platelet C4d is associated with acute ischemic stroke and stroke severity. Stroke. 2008 ; 39: 3236-3241